During the past decade, Az Nikolaas Campus Sint Niklaas conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Az Nikolaas Campus Sint Niklaas" are "Arthritis" (1 trials), "Avascular Necrosis" (1 trials), "End-stage Renal Disease" (1 trials), "Hemodiafiltration" (1 trials) and "Hemodialysis" (1 trials). Many other conditions were trialed in "Az Nikolaas Campus Sint Niklaas" in a lesser frequency.

Most popular intervention types in "Az Nikolaas Campus Sint Niklaas" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BAY1213790 (Osocimab)" (1 trials), "Placebo" (1 trials) and "ReCap Total Hip Resurfacing System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Az Nikolaas Campus Sint Niklaas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Az Nikolaas Campus Sint Niklaas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Az Nikolaas Campus Sint Niklaas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Az Nikolaas Campus Sint Niklaas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".